Sorrento Therapeutics Inc (NASDAQ:SRNE)

8.46
Real-Time Quote
 -0.04 / -0.47%
Today’s Change
3.10
Today|||52-Week Range
16.40
+4.44%
Year-to-Date
SECTOR
Miscellaneous
INDUSTRY
Miscellaneous
MARKET CAP
$245.9M

Company Description

Sorrento Therapeutics is engaged in the acquisition, discovery, development and commercialization of proprietary drug therapeutics that address significant unmet medical needs. Sorrento's primary therapeutic focus is cancer although its products and technologies have much broader clinical applications including autoimmune disorders, metabolic and infectious diseases. Sorrento's clinical pipeline includes Cynviloq (paclitaxel in polymeric micelle formulation) which is entering a registrational bio-equivalent study versus albumin-bound paclitaxel (Abraxane, Celgene); and Resiniferatoxin (RTX), which is in a Phase 1/2 study at the NIH to treat terminal cancer patients suffering from intractable pain. In addition, Sorrento has one of the industry's most diverse fully human antibody libraries (G-MAB) and novel toxins/proprietary conjugation chemistries allowing Sorrento to generate antibody-drug conjugates (ADCs). The Sorrento ADCs have well-defined drug antibody ratios (DAR) in contrast to approved ADCs, which are heterogeneous mixtures with different DARs. These differentiating characteristics may lead to the development of a new of generation ADCs with improved stability and pharmacokinetics while reducing off-target effects. Sorrento Therapeutics was founded by Henry Ji, in 2006 and is headquartered in San Diego, CA.

Contact Information

Sorrento Therapeutics, Inc.
6042 Cornerstone Court West
San Diego California 92121
P:(858) 210-3700
Investor Relations:

Employees

Shareholders

Mutual fund holders9.67%
Individual stakeholders28.09%
Other institutional27.47%

Top Executives

Henry H. JiPresident, Chief Executive Officer & Director
Richard Glenn VincentChief Financial Officer, Secretary & EVP
Zhenwei MiaoChief Technology Officer
Mike A. RoyalExecutive VP-Clinical & Regulatory Affairs
Amar SinghChief Business Officer & Executive Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.